Literature DB >> 31057085

Vasoactive Agents for Adult Septic Shock: An Update and Review.

Mark A Dalimonte1, Jeremy R DeGrado1, Kevin E Anger2.   

Abstract

PURPOSE: The objective of this article is to discuss the pharmacology, side effects, and clinical application of vasoactive therapy in the management of adult septic shock.
SUMMARY: Sepsis is one of the most common reasons for admission to an intensive care unit with the incidence estimated to be greater than 750 000 cases per year in the United States. Clinicians should understand the basic pharmacology of available vasoactive agents to allow for routine and complex management of septic shock.
CONCLUSION: While advances in research, identification, and early implementation of best practices for the treatment of sepsis has reduced mortality, rates remain high. Vasopressors and inotropes remain part of the core therapeutic modalities of sepsis management. Norepinephrine is the first-line vasopressor of choice for septic shock, though secondary vasopressors can be used depending on the patient's circumstances.

Entities:  

Keywords:  sepsis; septic shock; vasoactive agent

Mesh:

Substances:

Year:  2019        PMID: 31057085     DOI: 10.1177/0897190019844124

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  3 in total

1.  Effect Evaluation of Norepinephrine on Cardiac Function in Patients with Sepsis by Cardiac Ultrasound Imaging.

Authors:  Wei Zhou; Yuyu Li; Baocheng Yang; Xianjun Wang
Journal:  Comput Math Methods Med       Date:  2022-06-20       Impact factor: 2.809

2.  Predictors of Requirement of Inotrope Among Patients With Early Sepsis: Special Reference to Microcirculatory Parameters.

Authors:  Rishabh Bose; Gyanendra Singh; Prachi Singh; Ananyan Sampath; Ritik Singh; Bhupeshwari Patel; Abhijit P Pakhare; Rajnish Joshi; Sagar Khadanga
Journal:  Cureus       Date:  2022-05-05

Review 3.  Insights Into Thiamine Supplementation in Patients With Septic Shock.

Authors:  Nara Aline Costa; Amanda Gomes Pereira; Clara Sandra Araujo Sugizaki; Nayane Maria Vieira; Leonardo Rufino Garcia; Sérgio Alberto Rupp de Paiva; Leonardo Antonio Mamede Zornoff; Paula Schmidt Azevedo; Bertha Furlan Polegato; Marcos Ferreira Minicucci
Journal:  Front Med (Lausanne)       Date:  2022-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.